# Compassionate Use of Opaganib in Patients With Coronavirus Disease 2019 (COVID-19)

> **NCT04435106** · — · COMPLETED · sponsor: **Shaare Zedek Medical Center** · enrollment: 23 (actual)

## Conditions studied

- Coronavirus Infections

## Interventions

- **DRUG:** Opaganib
- **DRUG:** Standard of Care

## Key facts

- **NCT ID:** NCT04435106
- **Lead sponsor:** Shaare Zedek Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-03
- **Primary completion:** 2020-05-01
- **Final completion:** 2020-05-15
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2020-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04435106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04435106, "Compassionate Use of Opaganib in Patients With Coronavirus Disease 2019 (COVID-19)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04435106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*